Nebula is free while in beta — browse the evidence map with no account.Open Nebula →
AEaH.aiEvidence · Intelligence

trial · primary record

Ninerafaxstat 200mg MR

Non-obstructive Hypertrophic Cardiomyopathy

PhasePhase 2
StatusRECRUITING
SponsorUnknown
Enrolment165
Primary completion2026-12
Primary endpointChange in Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS)
Registry IDNCT07023614

Provenance

  • Source: ClinicalTrials.gov
  • Fetched at: 2026-10-28T02:32:10.666Z
  • Licence class: attribution-required
  • Verdict: primary-source
  • Entity id: NCT07023614

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

Start monitoring — $199/monthAll trial records
Ninerafaxstat 200mg MR — trial | AEaH